Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracoronary Infusion of Alprostadil and Nitroglycerin With Targeted Perfusion Microcatheter in STEMI Patients With Coronary Slow Flow Phenomenon

NCT03296670 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03296670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracoronary Infusion of Alprostadil and Nitroglycerin With Targeted Perfusion Microcatheter in STEMI Patients With Coronary Slow Flow Phenomenon
Lead sponsor
RenJi Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2015
Completion date
August 31, 2017
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary slow flow phenomenon, st segment elevation myocardial infarction